Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.
Rossetti S, D'Aniello C, Iovane G, Scagliarini S, Laterza MM, De Vita F, Savastano C, Cartenì G, Porricelli MA, Berretta M, Pisconti S, Facchini G, Cavaliere C. Rossetti S, et al. Among authors: pisconti s. Front Pharmacol. 2017 Jul 20;8:484. doi: 10.3389/fphar.2017.00484. eCollection 2017. Front Pharmacol. 2017. PMID: 28775690 Free PMC article.
Maintenance therapy in colon cancer.
Giuliani F, De Vita F, Colucci G, Pisconti S. Giuliani F, et al. Among authors: pisconti s. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S42-5. doi: 10.1016/S0305-7372(10)70019-0. Cancer Treat Rev. 2010. PMID: 21129609 Review.
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.
Silvestris N, Pantano F, Ibrahim T, Gamucci T, De Vita F, Di Palma T, Pedrazzoli P, Barni S, Bernardo A, Febbraro A, Satolli MA, Bertocchi P, Catalano V, Giommoni E, Comandone A, Maiello E, Riccardi F, Ferrara R, Trogu A, Berardi R, Leo S, Bertolini A, Angelini F, Cinieri S, Russo A, Pisconti S, Brunetti AE, Azzariti A, Santini D. Silvestris N, et al. Among authors: pisconti s. PLoS One. 2013 Oct 28;8(10):e74402. doi: 10.1371/journal.pone.0074402. eCollection 2013. PLoS One. 2013. PMID: 24204569 Free PMC article.
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.
Ciardiello F, Normanno N, Maiello E, Martinelli E, Troiani T, Pisconti S, Giuliani F, Barone C, Cartenì G, Rachiglio AM, Montesarchio V, Tonini G, Rizzi D, Cinieri S, Bordonaro R, Febbraro A, De Vita F, Orditura M, Fenizia F, Lambiase M, Rinaldi A, Tatangelo F, Botti G, Colucci G. Ciardiello F, et al. Among authors: pisconti s. Ann Oncol. 2014 Sep;25(9):1756-1761. doi: 10.1093/annonc/mdu230. Epub 2014 Jun 18. Ann Oncol. 2014. PMID: 24942275 Free article.
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen.
Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P. Perri F, et al. Among authors: pisconti s. Onco Targets Ther. 2015 Jun 8;8:1345-9. doi: 10.2147/OTT.S75232. eCollection 2015. Onco Targets Ther. 2015. PMID: 26089683 Free PMC article.
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.
Ciardiello F, Normanno N, Martinelli E, Troiani T, Pisconti S, Cardone C, Nappi A, Bordonaro AR, Rachiglio M, Lambiase M, Latiano TP, Modoni G, Cordio S, Giuliani F, Biglietto M, Montesarchio V, Barone C, Tonini G, Cinieri S, Febbraro A, Rizzi D, De Vita F, Orditura M, Colucci G, Maiello E; CAPRI-GOIM investigators. Ciardiello F, et al. Among authors: pisconti s. Ann Oncol. 2016 Jun;27(6):1055-1061. doi: 10.1093/annonc/mdw136. Epub 2016 Mar 21. Ann Oncol. 2016. PMID: 27002107 Free article. Clinical Trial.
From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples.
Facchini G, Della Pepa C, Cavaliere C, Cecere SC, Di Napoli M, D'Aniello C, Crispo A, Iovane G, Maiolino P, Tramontano T, Piscitelli R, Pisconti S, Montella M, Berretta M, Sorrentino D, Perdonà S, Pignata S. Facchini G, et al. Among authors: pisconti s. Front Pharmacol. 2016 May 3;7:110. doi: 10.3389/fphar.2016.00110. eCollection 2016. Front Pharmacol. 2016. PMID: 27199753 Free PMC article.
Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival.
Facchini G, Caffo O, Ortega C, D'Aniello C, Di Napoli M, Cecere SC, Della Pepa C, Crispo A, Maines F, Ruatta F, Iovane G, Pisconti S, Montella M, Berretta M, Pignata S, Cavaliere C. Facchini G, et al. Among authors: pisconti s. Front Pharmacol. 2016 May 18;7:123. doi: 10.3389/fphar.2016.00123. eCollection 2016. Front Pharmacol. 2016. PMID: 27242530 Free PMC article.
114 results